REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/06/2026
Back to search
Official data from USPTO
RCT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
63
Latest update
04/07/2026
Trademark type
Word
Nice classes
5
Filing date
01/03/2017
Registration date
04/06/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/06/2021
Last transaction
04/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/15/2019
First use in commerce
10/15/2019
Drawing code
4
Owner type
03
Owner location
Cambridge, MA, US
Examiner
VALLILLO, MELISSA C
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Rubius Therapeutics, Inc.
Representatives
Christina M. Licursi WOLF GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditionscancerinflammatory diseases and disordersautoimmune diseases and disordersmetabolic diseases and disordersgenetic diseases and disordersinfectious diseases and disorderscardiovascular diseases and disorders; pharmaceutical preparations of engineered eythroid cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditionscancerinflammatory diseases and disordersautoimmune diseases and disordersmetabolic diseases and disordersgenetic diseases and disordersinfectious diseases and disorderscardiovascular diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of a variety of human and animal diseases and conditionscancerinflammatory diseases and disordersautoimmune diseases and disordersmetabolic diseases and disordersgenetic diseases and disordersinfectious diseases and disorderscardiovascular diseases and disordersnone of the foregoing related chemical researchresearch services in connection with physics and engineering researchto photovoltaic installations
Publications
History of USPTO decisions and trademark events.
63 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/06/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/03/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/18/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/30/2020
GNFR
FINAL REFUSAL E-MAILED
09/30/2020
CNFR
SU - FINAL REFUSAL - WRITTEN
09/30/2020
MREI
NOTICE OF REINSTATEMENT E-MAILED
09/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2020
RGIA
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
09/08/2020
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
09/03/2020
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
09/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/13/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2020
GNRT
NON-FINAL ACTION E-MAILED
02/13/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/13/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/29/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/28/2020
EX4G
SOU EXTENSION 4 GRANTED
01/28/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/28/2020
IUAF
USE AMENDMENT FILED
01/23/2020
EXT4
SOU EXTENSION 4 FILED
01/23/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/23/2020
EISU
TEAS STATEMENT OF USE RECEIVED
01/23/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/25/2019
EX3G
SOU EXTENSION 3 GRANTED
07/23/2019
EXT3
SOU EXTENSION 3 FILED
07/23/2019
EEXT
SOU TEAS EXTENSION RECEIVED
07/23/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/06/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/06/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/25/2019
EX2G
SOU EXTENSION 2 GRANTED
01/23/2019
EXT2
SOU EXTENSION 2 FILED
01/23/2019
EEXT
SOU TEAS EXTENSION RECEIVED
01/23/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/24/2018
EX1G
SOU EXTENSION 1 GRANTED
07/20/2018
EXT1
SOU EXTENSION 1 FILED
07/20/2018
EEXT
SOU TEAS EXTENSION RECEIVED
07/20/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/02/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/02/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/23/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/28/2017
PUBO
PUBLISHED FOR OPPOSITION
11/28/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/26/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/20/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
10/20/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/20/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
10/20/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/20/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/16/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2017
ALIE
ASSIGNED TO LIE
10/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/29/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/04/2017
GNRT
NON-FINAL ACTION E-MAILED
04/04/2017
CNRT
NON-FINAL ACTION WRITTEN
04/04/2017
DOCK
ASSIGNED TO EXAMINER
03/28/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2017
Continuous trademark protection
Get notified about every new filing that threatens RCT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.